NL7702548A - Werkwijze ter bereiding van 3,7-digesubstitueerde- -3-cefem-4-carbonzuurverbindingen, alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten. - Google Patents

Werkwijze ter bereiding van 3,7-digesubstitueerde- -3-cefem-4-carbonzuurverbindingen, alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten.

Info

Publication number
NL7702548A
NL7702548A NL7702548A NL7702548A NL7702548A NL 7702548 A NL7702548 A NL 7702548A NL 7702548 A NL7702548 A NL 7702548A NL 7702548 A NL7702548 A NL 7702548A NL 7702548 A NL7702548 A NL 7702548A
Authority
NL
Netherlands
Prior art keywords
ceutic
cefem
pharma
dig
substituted
Prior art date
Application number
NL7702548A
Other languages
English (en)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NL7702548A publication Critical patent/NL7702548A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/50—Nitrogen atoms bound to hetero atoms
    • C07D277/52—Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NL7702548A 1976-03-09 1977-03-09 Werkwijze ter bereiding van 3,7-digesubstitueerde- -3-cefem-4-carbonzuurverbindingen, alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten. NL7702548A (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9425/76A GB1575803A (en) 1976-03-09 1976-03-09 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
GB4114576 1976-10-04
GB29662/79A GB1575804A (en) 1976-03-09 1977-02-24 Substituted thiazole intermediates in the preparation of 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof

Publications (1)

Publication Number Publication Date
NL7702548A true NL7702548A (nl) 1977-09-13

Family

ID=27255362

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7702548A NL7702548A (nl) 1976-03-09 1977-03-09 Werkwijze ter bereiding van 3,7-digesubstitueerde- -3-cefem-4-carbonzuurverbindingen, alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten.

Country Status (10)

Country Link
US (1) US4303655A (nl)
JP (1) JPS52108997A (nl)
AT (1) AT353958B (nl)
AU (1) AU513281B2 (nl)
BE (1) BE852194A (nl)
CH (3) CH633015A5 (nl)
DE (1) DE2710282C2 (nl)
FR (2) FR2343747A1 (nl)
GB (2) GB1575803A (nl)
NL (1) NL7702548A (nl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US4370326A (en) * 1977-09-13 1983-01-25 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and composition
FR2387235A1 (fr) * 1978-01-23 1978-11-10 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3,7-disubstitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus, ayant une forte activite antibacterienne
DE2822861A1 (de) * 1978-05-26 1979-11-29 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
EP0021688B1 (en) * 1979-06-07 1983-07-13 Yamanouchi Pharmaceutical Co., Ltd. 7-(thiazolylpropionamido) cephalosporins, their preparation, and pharmaceutical compositions containing them
JPS55164690A (en) * 1979-06-07 1980-12-22 Yamanouchi Pharmaceut Co Ltd 7- 2- 2-aminothiazole-4-yl 3-hydroxypropionamide cephalosporin compound and its preparation
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
JPS5821682A (ja) * 1981-07-31 1983-02-08 Sankyo Co Ltd セファロスポリン誘導体
JPS5877886A (ja) * 1981-11-02 1983-05-11 Toyama Chem Co Ltd 新規セフアロスポリン類
US4704457A (en) * 1982-06-21 1987-11-03 E. R. Squibb & Sons, Inc. Process for the preparation of (3S)-3-[[[2-(protected amino)-4-thiazolyl]-oxoacetyl]amino]-2-oxo-1-azetidinesulfonic acid and 4-substituted derivatives thereof
FR2533216A1 (fr) * 1982-09-22 1984-03-23 Toyama Chemical Co Ltd Nouvelles cephalosporines, et leurs sels
JPS59164785A (ja) * 1983-03-10 1984-09-17 Nippon Synthetic Chem Ind Co Ltd:The ２−（２−アミノ−５−チアゾリル）−２−ヒドロキシ酢酸エステル及びその製造法
AT381944B (de) * 1984-04-10 1986-12-10 Biochemie Gmbh Verfahren zur herstellung von cephalosporinantibiotika
AT397963B (de) * 1985-03-29 1994-08-25 Shionogi & Co Verfahren zur herstellung von neuen 7 beta-(2-(2- amino-4-thiazolyl)-alkenoylamimo)-3-cephem-4- carbonsäureestern
AU580855B2 (en) * 1985-03-29 1989-02-02 Shionogi & Co., Ltd. Alkeneamidocephalosporin esters
DE3809561A1 (de) * 1988-03-22 1989-10-05 Hoechst Ag Ester der 7-(2-(2-aminothiazol-4-yl)-2-(z)- hydroxyiminoacetamido)-3-methoxymethyl-3-cephem-4-carbonsaeure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
MX2009009918A (es) 2007-03-23 2009-10-19 Basilea Pharmaceutica Ag Medicamentos combinados para el tratamiento de infecciones bacterianas.
EP3717465A1 (en) 2017-11-30 2020-10-07 Step Pharma S.A.S. Compounds
US11655246B2 (en) 2017-11-30 2023-05-23 Step Pharma S.A.S. Aminothiazole compounds as inhibitors of CTPS1
EP3870574B1 (en) 2018-10-23 2023-01-04 Step Pharma S.A.S. Aminopyrimidine/pyrazine derivatives as ctps1 inhibitors
US20230086703A1 (en) * 2019-06-04 2023-03-23 Step Pharma S.A.S. N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1208014A (en) * 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
GB1399086A (en) 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4093803A (en) * 1971-05-14 1978-06-06 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins
JPS5537555B2 (nl) * 1973-10-24 1980-09-29
NZ176206A (en) 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
FR2342733A1 (fr) * 1976-01-14 1977-09-30 Roussel Uclaf Derives de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
JPS603314B2 (ja) * 1976-08-31 1985-01-26 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法

Also Published As

Publication number Publication date
FR2343747B1 (nl) 1983-08-26
CH632761A5 (de) 1982-10-29
AU513281B2 (en) 1980-11-27
DE2710282C2 (de) 1986-09-25
DE2710282A1 (de) 1977-09-15
ATA153277A (de) 1979-05-15
AT353958B (de) 1979-12-10
CH633282A5 (de) 1982-11-30
FR2390429A1 (fr) 1978-12-08
FR2343747A1 (fr) 1977-10-07
JPS633867B2 (nl) 1988-01-26
BE852194A (fr) 1977-09-08
US4303655A (en) 1981-12-01
CH633015A5 (de) 1982-11-15
GB1575803A (en) 1980-10-01
JPS52108997A (en) 1977-09-12
GB1575804A (en) 1980-10-01
FR2390429B1 (nl) 1982-07-09
AU2271577A (en) 1978-08-31

Similar Documents

Publication Publication Date Title
NL7702548A (nl) Werkwijze ter bereiding van 3,7-digesubstitueerde- -3-cefem-4-carbonzuurverbindingen, alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten.
NL7714329A (nl) Werkwijze ter bereiding van 3-de-0-methylforti- micinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7502664A (nl) Werkwijze ter bereiding van antibiotische aculeacinen, alsmede preparaten die deze ver- bindingen als actieve component bevatten.
NL7708741A (nl) Werkwijze ter bereiding van prostaanzuurderiva- ten alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten.
NL7712567A (nl) Werkwijze ter bereiding van trigesubstitueerde 1-fenyl-2,3,4,5-tetrahydro-1h-3-benzazepine verbindingen, alsmede farmaceutische prepara- ten die deze verbindingen als actieve component bevatten.
NL7710389A (nl) Werkwijze ter bereiding van gesubstitueerde 6-fenyl-1,2,4-triazool /4,3-b/ pyridazinen, alsmede farmaceutische preparaten die deze verbindingen als actieve component omvatten.
NL7700379A (nl) Werkwijze ter bereiding van anthracyclinegly- cosiden, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7709697A (nl) Werkwijze ter bereiding van thiazolidinederivaten, alsmede farmaceutische preparaten die deze ver- bindingen als actieve component bevatten.
NL7603193A (nl) Werkwijze ter bereiding van acyclische, alicycli- sche en aromatische n-gesubstitueerde halogeen-2- -pyrrolidinonen met herbicidewerking alsmede her- bicidepreparaten die deze verbindingen als actie- ve component bevatten.
NL7706064A (nl) Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten.
NL7808475A (nl) Anthrachinonverbindingen, werkwijzen ter bereiding daarvan alsmede samenstellingen en preparaten die deze verbindingen als actieve component bevatten.
BE857181A (nl) Werkwijze ter bereiding van n-alkynyl-&-(gesugstitueerde fenoxy) alkylamiden met herbicidewerking alsmede herbicide-preparaten die deze verbindingen als actieve component bevatten
NL7707308A (nl) Werkwijze ter bereiding van 2-broom-6-fluor- -n-2-imidazolidinylideenbenzamide en de zuur- additiezouten daarvan en van preparaten, die deze verbindingen bevatten.
NL7705141A (nl) Werkwijze ter bereiding van prostaglandine deri- vaten, alsmede farmaceutische preparaten die deze verbinding als actieve component bevatten.
NL7708982A (nl) Werkwijze ter bereiding van dihydro-oxo-nicotine- zuren, alsmede farmaceutische preparaten die de- ze verbinding als actieve component bevatten.
NL7607975A (nl) Werkwijze ter bereiding van difenylsulfiden alsmede farmaceutische preparaten die deze verbindingen als actieve component omvatten.
NL7711414A (nl) Werkwijze ter bereiding van n-gesubstitueerde lactamen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7613041A (nl) Werkwijze ter bereiding van picolinezuurderiva- ten alsmede preparaten die deze verbindingen als actieve component omvatten.
NL7707150A (nl) Werkwijze ter bereiding van 2-lagere alkyl-7-ge- substitueerde-2 of 3-cefem-4-carbonzuurverbin- dingen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7702180A (nl) Werkwijze ter bereiding van 9-gesubstitueerde- -8-azapurinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7412659A (nl) Werkwijze ter bereiding van thienylfenyl o-(aminoalkyl)-ketonoximen en furylfenyl o-(aminoalkyl)-ketonoximen alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten.
NL7613334A (nl) Werkwijze ter bereiding van carbamaat-sulfenyl- -carbamoylfluorideverbindingen, alsmede pestici- de preparaten die deze verbindingen als actieve component omvatten.
NL7412302A (nl) Werkwijze ter bereiding van pyrazoliumverbindin- gen, alsmede herbicide preparaten die deze ver- bindingen als actieve component bevatten.
NL7714063A (nl) Werkwijze ter bereiding van imidazolinen alsmede pesticidepreparaten die deze verbindingen als actieve component bevatten.
NL7708377A (nl) Werkwijze ter bereiding van farmacologisch ac- tieve verbindingen alsmede preparaten die deze verbindingen als actieve component omvatten.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed